GET4

guided entry of tail-anchored proteins factor 4, the group of GET4-GET5 transmembrane domain recognition complex subunits|BAG6 complex

Basic information

Region (hg38): 7:876554-896436

Previous symbols: [ "C7orf20" ]

Links

ENSG00000239857NCBI:51608OMIM:612056HGNC:21690Uniprot:Q7L5D6AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • congenital disorder of glycosylation, type IIy (Limited), mode of inheritance: AR
  • congenital disorder of glycosylation, type IIy (Limited), mode of inheritance: Unknown

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Congenital disorder of glycosylation,, type IIyARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic32395830

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the GET4 gene.

  • not_specified (53 variants)
  • not_provided (7 variants)
  • Congenital_disorder_of_glycosylation,_type_IIy (2 variants)
  • GET4_deficiency (2 variants)
  • GET4-related_disorder (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the GET4 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000015949.3. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
5
clinvar
2
clinvar
7
missense
54
clinvar
54
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
0
Total 0 0 54 5 2
Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
GET4protein_codingprotein_codingENST00000265857 919885
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.5620.438125709091257180.0000358
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.1681841910.9660.00001232097
Missense in Polyphen3056.3650.53224610
Synonymous-4.8614486.51.660.00000624637
Loss of Function2.93315.40.1946.59e-7193

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00005840.0000584
Ashkenazi Jewish0.0001010.0000993
East Asian0.000.00
Finnish0.00004640.0000462
European (Non-Finnish)0.00003580.0000352
Middle Eastern0.000.00
South Asian0.000.00
Other0.0001660.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: As part of a cytosolic protein quality control complex, the BAG6/BAT3 complex, maintains misfolded and hydrophobic patches-containing proteins in a soluble state and participates to their proper delivery to the endoplasmic reticulum or alternatively can promote their sorting to the proteasome where they undergo degradation (PubMed:20676083, PubMed:21636303, PubMed:21743475, PubMed:28104892). The BAG6/BAT3 complex is involved in the post-translational delivery of tail-anchored/type II transmembrane proteins to the endoplasmic reticulum membrane. Recruited to ribosomes, it interacts with the transmembrane region of newly synthesized tail-anchored proteins and together with SGTA and ASNA1 mediates their delivery to the endoplasmic reticulum (PubMed:20676083, PubMed:28104892, PubMed:25535373). Client proteins that cannot be properly delivered to the endoplasmic reticulum are ubiquitinated and sorted to the proteasome (PubMed:28104892). Similarly, the BAG6/BAT3 complex also functions as a sorting platform for proteins of the secretory pathway that are mislocalized to the cytosol either delivering them to the proteasome for degradation or to the endoplasmic reticulum (PubMed:21743475). The BAG6/BAT3 complex also plays a role in the endoplasmic reticulum-associated degradation (ERAD), a quality control mechanism that eliminates unwanted proteins of the endoplasmic reticulum through their retrotranslocation to the cytosol and their targeting to the proteasome. It maintains these retrotranslocated proteins in an unfolded yet soluble state condition in the cytosol to ensure their proper delivery to the proteasome (PubMed:21636303). {ECO:0000269|PubMed:20676083, ECO:0000269|PubMed:21636303, ECO:0000269|PubMed:21743475, ECO:0000269|PubMed:25535373, ECO:0000269|PubMed:28104892}.;

Recessive Scores

pRec
0.0954

Intolerance Scores

loftool
rvis_EVS
-1.27
rvis_percentile_EVS
5.24

Haploinsufficiency Scores

pHI
0.187
hipred
Y
hipred_score
0.640
ghis
0.636

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.969

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Get4
Phenotype

Gene ontology

Biological process
protein insertion into ER membrane;cytoplasmic sequestering of protein;tail-anchored membrane protein insertion into ER membrane;maintenance of unfolded protein involved in ERAD pathway
Cellular component
nucleoplasm;nucleolus;cytoplasm;cytosol;BAT3 complex
Molecular function
protein binding;chaperone binding